Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy (Q35140423)

6 August 2017

title

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy (English)

1 reference

6 August 2017

1 reference

13

George L Drusano

1 reference

6 August 2017

2

Arnold Louie

1 reference

6 August 2017

Nelson Jumbe

1

1 reference

6 August 2017

Robert Leary

3

1 reference

6 August 2017

Weiguo Liu

4

1 reference

6 August 2017

Mark R Deziel

5

1 reference

6 August 2017

Vincent H Tam

6

1 reference

6 August 2017

Reetu Bachhawat

7

1 reference

6 August 2017

Christopher Freeman

8

1 reference

6 August 2017

James B Kahn

9

1 reference

6 August 2017

Karen Bush

10

1 reference

6 August 2017

Michael N Dudley

11

1 reference

6 August 2017

Michael H Miller

12

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Journal of Clinical Investigation

6 August 2017

published in

1 reference

6 August 2017

volume

112

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

275-285

1 reference

6 August 2017

cites work

Does the dose matter?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

The population dynamics of antimicrobial chemotherapy.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Proton-dependent multidrug efflux systems

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Prevention of drug access to bacterial targets: permeability barriers and active efflux

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

DNA gyrase on the bacterial chromosome: possibility of two levels of action

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164285

Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12865415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12865415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12865415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1172/JCI200316814

1 reference

6 August 2017

1 reference

6 August 2017

1 reference